2Hiroaki Y,Katsuji T,Rytaro Y,et al.Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase:its possible occurrence in cancer patients[J].Proc Nad Acad Sci,1986,83:6622.
3Uyttenhove C,Pilotte L,Theate I,et al.Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J].Nature Med,2003,9(7):1269.
4Travers MT,Gow IF,Barber J,et al.Thomson Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells[J].Biochim Biophy Acta,2004,1661(1):106.
5Katharina S,Christiana W,Lothar CF,et al.Tryptophan degradation in patients with gynecological cancer correlates with immune activation[J].Cancer Lett,2005,223:323.
6Munn DH.Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumordraining lymph nodes[J].J Clin Invest,2004,114:280.
7Fallarino F.Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells[J].Int.Immunol,2002,14:65.
8Munn DH.Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase[J].Science,2002,297:1867.
9Simonetta A,Barbara M,Roberta C,et al.Eosinophil granulocytes account for indoleamine 2,3-Dioxygenase-mediated immune escape in human non-small cell lung cancer[J].Neoplasia,2005,7(4):390.
10Lee GK,Park HJ,Macleod M,et al.Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division[J].Immunology,2002,107(4):452.
